Compound

Risperidone

ATC Index

Risperidone: Uses, Dosage, Side Effects & Prescription Info

Explore comprehensive information on Risperidone, an atypical antipsychotic. Learn about its uses for schizophrenia, bipolar disorder, and autism, its dosage, common side effects, and how it helps manage severe mental health conditions.

Risperidone buy Risperidone Risperidone for sale Risperidone dosage Risperidone side effects atypical antipsychotic schizophrenia treatment bipolar disorder medication
ATC Code: N05
Last updated: Feb 23, 2026
Medical Reference

Looking to order Risperidone?

Browse our catalog for available pharmaceutical products and competitive pricing.

View Products

What is Risperidone?

Risperidone is a widely recognized pharmaceutical compound classified as an atypical antipsychotic medication. It is primarily used in the management of several serious mental health conditions, including schizophrenia, bipolar I disorder (specifically manic or mixed episodes), and irritability associated with autistic disorder in children and adolescents. Its efficacy stems from its complex interaction with neurotransmitter systems in the brain, offering a broader spectrum of action compared to older, typical antipsychotics. Patients often experience significant improvements in thought processes, mood stabilization, and behavioral control, which can dramatically enhance their quality of life and functional capacity.

The development of Risperidone marked a significant advancement in psychopharmacology. It was first synthesized by Janssen Pharmaceutica in the 1980s and received its initial approval from the U.S. Food and Drug Administration (FDA) in 1993. Its introduction provided a new option for patients who either did not respond well to or experienced intolerable side effects from conventional antipsychotics. The drug's balanced receptor binding profile was engineered to mitigate some of the debilitating extrapyramidal side effects (EPS) commonly associated with first-generation antipsychotics, thereby improving patient adherence and overall treatment outcomes. This historical context highlights its role as a cornerstone in modern psychiatric care.

As a member of the benzisoxazole derivative class, Risperidone is categorized under the Anatomical Therapeutic Chemical (ATC) code N05. This code specifically identifies it within the 'Psycholeptics, Antipsychotics' group, underscoring its primary therapeutic application. Its designation as an 'atypical' or 'second-generation' antipsychotic distinguishes it from 'typical' or 'first-generation' agents by its mechanism of action, which involves both dopamine and serotonin receptor antagonism. This dual action is believed to contribute to its broader efficacy profile, addressing both positive and negative symptoms of psychosis, as well as mood stabilization, with a potentially more favorable side effect profile in certain aspects.

⚙️ Mechanism of Action

The therapeutic efficacy of Risperidone is primarily attributed to its potent antagonism of both dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. This dual mechanism is a hallmark of atypical antipsychotics and is believed to contribute to its ability to alleviate a wide range of symptoms associated with conditions like schizophrenia and bipolar disorder. By blocking D2 receptors, Risperidone reduces excessive dopaminergic activity, which is thought to be a key factor in the positive symptoms of psychosis, such as hallucinations and delusions. Concurrently, its strong antagonism of 5-HT2A receptors is hypothesized to modulate dopamine release in specific brain regions, particularly the prefrontal cortex, which can improve cognitive function and negative symptoms (e.g., apathy, social withdrawal) often less responsive to D2-only antagonists. This balanced action helps to reduce the risk of extrapyramidal side effects compared to typical antipsychotics, which primarily target D2 receptors.

Beyond its primary D2 and 5-HT2A receptor antagonism, Risperidone also exhibits affinity for other neurotransmitter receptors, albeit to varying degrees, which may contribute to its overall pharmacological profile and potential side effects. It acts as an antagonist at alpha1-adrenergic receptors and, to a lesser extent, at alpha2-adrenergic and H1-histaminergic receptors. Antagonism of alpha1-adrenergic receptors can contribute to orthostatic hypotension, a common side effect, while H1-histamine receptor blockade may lead to sedation and weight gain. The precise interplay of these receptor interactions allows Risperidone to exert its broad therapeutic effects, stabilizing mood, reducing psychotic symptoms, and managing behavioral disturbances across its approved indications, making it a versatile agent in psychiatric treatment.

  • Potent antagonist of dopamine D2 receptors, reducing positive psychotic symptoms.
  • Strong antagonist of serotonin 5-HT2A receptors, improving negative symptoms and cognition.
  • Modulates dopamine and serotonin pathways, contributing to mood stabilization.
  • Affinity for alpha1-adrenergic receptors, potentially causing orthostatic hypotension.
  • Weak antagonism of H1-histaminergic receptors, contributing to sedation and weight gain.

🏥️ Medical Uses & Indications

Risperidone is a versatile medication with established efficacy across a spectrum of psychiatric disorders. Its broad therapeutic profile makes it a valuable tool for clinicians managing complex conditions that affect thought, mood, and behavior. The primary goal of treatment with Risperidone is to alleviate debilitating symptoms, improve functional capacity, and enhance the overall quality of life for patients. It is available in various formulations, including oral tablets, orally disintegrating tablets, oral solution, and a long-acting injectable form, offering flexibility in administration to suit individual patient needs and adherence challenges.

Primary Indications

  • Schizophrenia: Approved for the treatment of schizophrenia in adults and adolescents (13-17 years). It effectively manages both positive symptoms (hallucinations, delusions) and negative symptoms (apathy, social withdrawal).
  • Bipolar I Disorder (Manic or Mixed Episodes): Indicated as monotherapy or adjunctive therapy with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults and adolescents (10-17 years).
  • Bipolar I Disorder (Maintenance Treatment): Approved for maintenance treatment of Bipolar I Disorder in adults as adjunctive therapy to lithium or valproate.
  • Irritability Associated with Autistic Disorder: Approved for the treatment of irritability associated with autistic disorder in children and adolescents (5-16 years), addressing symptoms such as aggression, deliberate self-injury, and temper tantrums.
  • Aggression in Dementia: While not a primary indication, it is sometimes used with caution in elderly patients with severe aggression or psychotic symptoms associated with dementia when non-pharmacological interventions are insufficient.
  • Tourette's Syndrome: In some cases, Risperidone may be used off-label to manage severe tics and associated behavioral problems in Tourette's Syndrome, especially when other treatments have failed.

Secondary / Off-label Uses

  • Depression with Psychotic Features: Can be used as an adjunctive treatment for severe depression when psychotic features are present and unresponsive to standard antidepressant therapy.
  • Delirium: Occasionally used to manage acute agitation and psychotic symptoms in patients experiencing delirium, particularly in palliative care settings, with careful monitoring.
  • Obsessive-Compulsive Disorder (OCD): May be prescribed as an augmentation strategy for patients with severe, treatment-resistant OCD who have not responded adequately to selective serotonin reuptake inhibitors (SSRIs).
  • Behavioral Disturbances in Developmental Disorders: Beyond autism, it can be considered for severe behavioral issues, aggression, or self-injurious behavior in other developmental disorders, always with careful risk-benefit assessment.

💊 Dosage & Administration

The dosage of Risperidone must be carefully individualized based on the patient's specific diagnosis, age, weight, renal and hepatic function, concomitant medications, and overall response and tolerability. Treatment typically begins with a low dose, which is then gradually titrated upwards to achieve the optimal therapeutic effect while minimizing side effects. It is crucial to adhere strictly to the prescribing physician's instructions and never adjust the dosage or discontinue the medication without medical guidance. Risperidone is available in oral tablets, orally disintegrating tablets (ODT), and oral solution, offering flexibility for administration. A long-acting injectable formulation (Risperdal Consta) is also available for maintenance treatment, providing sustained release over two weeks.

IndicationTypical DoseFrequencyRoute
Schizophrenia (Adults)Initial: 0.5-2 mg/day; Target: 2-8 mg/dayOnce or Twice DailyOral
Bipolar Mania (Adults)Initial: 0.5-2 mg/day; Target: 1-6 mg/dayOnce or Twice DailyOral
Autism Irritability (Children/Adolescents)Initial: 0.25 mg/day; Target: 0.5-3 mg/day (based on weight)Once or Twice DailyOral
Schizophrenia (Maintenance, Adults)25-50 mg every 2 weeksEvery 2 WeeksIntramuscular Injection (Long-acting)

Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition. Close monitoring for therapeutic response and adverse effects is essential throughout treatment. Dose adjustments may be necessary in patients with renal or hepatic impairment, or those taking medications that interact with Risperidone's metabolism.

⚠️ Side Effects

Like all medications, Risperidone can cause side effects, although not everyone experiences them. The incidence and severity of side effects can vary depending on the dosage, individual patient sensitivity, and duration of treatment. It is important for patients to discuss any concerns about side effects with their healthcare provider.

Common Side Effects (>10%)

  • Sedation or somnolence (drowsiness)
  • Insomnia or difficulty sleeping
  • Weight gain
  • Extrapyramidal symptoms (EPS), such as parkinsonism (tremor, rigidity), akathisia (restlessness), and dystonia (muscle spasms)
  • Dizziness or lightheadedness, especially upon standing (orthostatic hypotension)
  • Nausea, vomiting, or abdominal pain
  • Rhinitis (runny nose)

Less Common (1-10%)

  • Tachycardia (rapid heartbeat)
  • Anxiety or agitation
  • Sexual dysfunction (e.g., erectile dysfunction, decreased libido)
  • Increased prolactin levels (can lead to menstrual irregularities, galactorrhea, gynecomastia)
  • Dry mouth or increased salivation
  • Constipation or diarrhea
  • Headache

Rare but Serious

  • Neuroleptic Malignant Syndrome (NMS): A rare but life-threatening neurological disorder characterized by high fever, severe muscle rigidity, altered mental status, and autonomic instability (e.g., irregular pulse or blood pressure). Requires immediate medical attention.
  • Tardive Dyskinesia (TD): Involuntary, repetitive movements, particularly of the face, tongue, and limbs. The risk increases with duration of treatment and higher doses. It can be irreversible in some cases.
  • Hyperglycemia and Diabetes: Atypical antipsychotics, including Risperidone, have been associated with metabolic changes, including elevated blood sugar, which can lead to new-onset diabetes or worsening of existing diabetes. Regular monitoring of blood glucose is recommended.
  • Cerebrovascular Adverse Events (CVAEs) in Elderly with Dementia: Increased risk of stroke or transient ischemic attack (TIA) in elderly patients with dementia-related psychosis treated with Risperidone. This is a black box warning.

🔄 Drug Interactions

Risperidone is primarily metabolized by the cytochrome P450 2D6 (CYP2D6) enzyme system and to a lesser extent by CYP3A4. Therefore, co-administration with drugs that inhibit or induce these enzymes can significantly alter Risperidone plasma concentrations, potentially leading to increased side effects or reduced efficacy. Additionally, caution is advised when Risperidone is used with other medications that affect the central nervous system or cardiovascular function.

  • CYP2D6 Inhibitors: Strong inhibitors of CYP2D6, such as fluoxetine and paroxetine (antidepressants), can increase the plasma concentration of the active antipsychotic fraction of Risperidone, potentially leading to increased side effects. Dose adjustments of Risperidone may be necessary.
  • CYP3A4 Inducers: Potent inducers of CYP3A4, such as carbamazepine (an anticonvulsant) and rifampin (an antibiotic), can significantly decrease the plasma concentration of the active antipsychotic fraction of Risperidone, potentially reducing its therapeutic effects. Dose adjustments of Risperidone may be required.
  • CNS Depressants: Co-administration with other centrally acting drugs, including alcohol, benzodiazepines, opioids, and antihistamines, can lead to additive CNS depression, resulting in increased sedation, dizziness, and respiratory depression.
  • Antihypertensive Agents: Due to its alpha1-adrenergic blocking activity, Risperidone can potentiate the hypotensive effects of antihypertensive medications, increasing the risk of orthostatic hypotension.
  • QT-Prolonging Drugs: Caution is advised when Risperidone is co-administered with other medications known to prolong the QT interval (e.g., certain antiarrhythmics, tricyclic antidepressants, some antibiotics), as this may increase the risk of cardiac arrhythmias.
  • Levodopa and Dopamine Agonists: Risperidone, being a dopamine D2 antagonist, can antagonize the effects of levodopa and other dopamine agonists, which are used to treat Parkinson's disease. This may worsen Parkinsonian symptoms.

🚫 Contraindications & Warnings

  • Hypersensitivity: Risperidone is contraindicated in patients with a known hypersensitivity to the drug or any of its components. Allergic reactions can include rash, itching, hives, swelling, and breathing difficulties.
  • Dementia-Related Psychosis in Elderly Patients: Risperidone is not approved for the treatment of psychosis related to dementia in elderly patients. Studies have shown an increased risk of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) and mortality in this population when treated with atypical antipsychotics.
  • Severe Central Nervous System (CNS) Depression: Use with extreme caution, or avoid, in patients with severe CNS depression or coma, as Risperidone can potentiate CNS depressant effects.
  • Uncontrolled Cardiovascular Conditions: Patients with severe cardiovascular disease (e.g., heart failure, history of myocardial infarction, ischemia, cerebrovascular disease, conditions predisposing to hypotension) should be treated with caution due to the risk of orthostatic hypotension.
  • Pheochromocytoma: Use with caution in patients with pheochromocytoma, as alpha-adrenergic blocking agents like Risperidone can exacerbate hypertension in this condition.
  • Parkinson's Disease or Lewy Body Dementia: Patients with Parkinson's disease or Lewy body dementia may be at an increased risk of NMS and increased sensitivity to antipsychotic medications, including severe extrapyramidal symptoms.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. The content provided here does not substitute for professional medical advice, diagnosis, or treatment.

❓ Frequently Asked Questions

Is Risperidone safe for long-term use?

Risperidone can be used safely for long-term treatment under the guidance of a healthcare professional. For chronic conditions like schizophrenia and bipolar disorder, long-term use is often necessary to prevent symptom relapse and maintain stability. However, long-term use requires regular monitoring for potential side effects, including metabolic changes (weight gain, elevated blood sugar and lipids), extrapyramidal symptoms, prolactin elevation, and cardiovascular health. Your doctor will assess the ongoing benefits versus risks to ensure continued safety and efficacy.

Can Risperidone be taken with food?

Yes, Risperidone can be taken with or without food. The absorption of Risperidone is not significantly affected by food, so patients can choose to take it in a way that is most convenient for them. Taking it with food might help reduce stomach upset for some individuals. Always follow your doctor's specific instructions regarding administration.

What should I do if I miss a dose of Risperidone?

If you miss a dose of Risperidone, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects. If you frequently miss doses or are unsure, contact your healthcare provider for advice.

Where can I buy Risperidone?

Risperidone is a prescription-only medication and cannot be purchased without a valid prescription from a licensed healthcare provider. It should only be obtained through legitimate and licensed medical channels, such as pharmacies, hospitals, or accredited online pharmacies that require a prescription. Attempting to buy Risperidone from unregulated sources can be dangerous, as the product may be counterfeit, contaminated, or incorrectly dosed, posing serious health risks. Always prioritize your safety and health by obtaining medications through proper legal and medical avenues.

Contact us on WhatsApp

Chat with our support team instantly on WhatsApp.

WhatsApp Chat on WhatsApp